Park Eugene, Velumian Alexander A, Fehlings Michael G
Division of Neurosurgery and Institute of Medical Science, University of Toronto, and Division of Cell and Molecular Biology, Toronto Western Research Institute, Toronto Western Hospital, University Health Network, Ontario, Canada.
J Neurotrauma. 2004 Jun;21(6):754-74. doi: 10.1089/0897715041269641.
Following an initial impact after spinal cord injury (SCI), there is a cascade of downstream events termed 'secondary injury', which culminate in progressive degenerative events in the spinal cord. These secondary injury mechanisms include, but are not limited to, ischemia, inflammation, free radical-induced cell death, glutamate excitotoxicity, cytoskeletal degradation and induction of extrinsic and intrinsic apoptotic pathways. There is emerging evidence that glutamate excitotoxicity plays a key role not only in neuronal cell death but also in delayed posttraumatic spinal cord white matter degeneration. Importantly however, the differences in cellular composition and expression of specific types of glutamate receptors in grey versus white matter require a compartmentalized approach to understand the mechanisms of secondary injury after SCI. This review examines mechanisms of secondary white matter injury with particular emphasis on glutamate excitotoxicity and the potential link of this mechanism to apoptosis. Recent studies have provided new insights into the mechanisms of glutamate release and its potential targets, as well as the downstream pathways associated with glutamate receptor activation in specific types of cells. Evidence from molecular and functional expression of glutamatergic AMPA receptors in white matter glia (and possibly axons), the protective effects of AMPA/kainate antagonists in posttraumatic white matter axonal function, and the vulnerability of oligodendrocytes to excitotoxic cell death suggest that glutamate excitotoxicity is associated with oligodendrocyte apoptosis. The latter mechanism appears key to glutamatergic white matter degeneration after SCI and may represent an attractive therapeutic target.
脊髓损伤(SCI)后,在最初的撞击之后,会发生一系列被称为“继发性损伤”的下游事件,这些事件最终导致脊髓中进行性的退行性病变。这些继发性损伤机制包括但不限于缺血、炎症、自由基诱导的细胞死亡、谷氨酸兴奋性毒性、细胞骨架降解以及外在和内在凋亡途径的诱导。越来越多的证据表明,谷氨酸兴奋性毒性不仅在神经元细胞死亡中起关键作用,而且在创伤后脊髓白质延迟性退变中也起关键作用。然而,重要的是,灰质和白质中特定类型谷氨酸受体的细胞组成和表达差异需要采用分区方法来理解SCI后继发性损伤的机制。本综述探讨继发性白质损伤的机制,特别强调谷氨酸兴奋性毒性以及该机制与凋亡的潜在联系。最近的研究为谷氨酸释放机制及其潜在靶点,以及特定类型细胞中与谷氨酸受体激活相关的下游途径提供了新的见解。来自白质胶质细胞(可能还有轴突)中谷氨酸能AMPA受体的分子和功能表达、AMPA/海人酸拮抗剂对创伤后白质轴突功能的保护作用,以及少突胶质细胞对兴奋性毒性细胞死亡的易感性的证据表明,谷氨酸兴奋性毒性与少突胶质细胞凋亡有关。后一种机制似乎是SCI后谷氨酸能白质退变的关键,可能是一个有吸引力的治疗靶点。